Brookside Capital Management Trimmed Its Vertex Pharmaceuticals (Call) (VRTX) Position; Bluestein R H & Company Has Boosted By $1.59 Million Its Union Pacific (UNP) Position

December 8, 2017 - By Adrian Mccoy

Brookside Capital Management Llc decreased Vertex Pharmaceuticals Inc (Call) (VRTX) stake by 99.1% reported in 2017Q2 SEC filing. Brookside Capital Management Llc sold 276,552 shares as Vertex Pharmaceuticals Inc (Call) (VRTX)’s stock rose 33.61%. The Brookside Capital Management Llc holds 2,521 shares with $3.30M value, down from 279,073 last quarter. Vertex Pharmaceuticals Inc (Call) now has $35.10B valuation. The stock increased 1.09% or $1.5 during the last trading session, reaching $138.78. About 1.69 million shares traded or 9.49% up from the average. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has risen 45.69% since December 8, 2016 and is uptrending. It has outperformed by 28.99% the S&P500.

Bluestein R H & Company increased Union Pacific Corp (UNP) stake by 3.89% reported in 2017Q2 SEC filing. Bluestein R H & Company acquired 14,702 shares as Union Pacific Corp (UNP)’s stock declined 2.52%. The Bluestein R H & Company holds 392,869 shares with $42.79 million value, up from 378,167 last quarter. Union Pacific Corp now has $101.12 billion valuation. The stock increased 0.40% or $0.51 during the last trading session, reaching $128.46. About 4.70 million shares traded or 33.08% up from the average. Union Pacific Corporation (NYSE:UNP) has risen 31.45% since December 8, 2016 and is uptrending. It has outperformed by 14.75% the S&P500.

Analysts await Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) to report earnings on January, 24. They expect $0.29 earnings per share, up 123.08% or $0.16 from last year’s $0.13 per share. VRTX’s profit will be $73.34 million for 119.64 P/E if the $0.29 EPS becomes a reality. After $0.24 actual earnings per share reported by Vertex Pharmaceuticals Incorporated for the previous quarter, Wall Street now forecasts 20.83% EPS growth.

Among 26 analysts covering Vertex Pharmaceuticals (NASDAQ:VRTX), 22 have Buy rating, 0 Sell and 4 Hold. Therefore 85% are positive. Vertex Pharmaceuticals had 77 analyst reports since July 31, 2015 according to SRatingsIntel. The stock of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) earned “Outperform” rating by Leerink Swann on Friday, February 5. The rating was upgraded by Barclays Capital to “Overweight” on Monday, September 14. The stock has “Hold” rating by Vetr on Monday, August 17. The stock of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) earned “Buy” rating by Jefferies on Thursday, October 26. The rating was upgraded by H.C. Wainwright to “Buy” on Friday, October 30. Credit Suisse initiated Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) rating on Wednesday, January 20. Credit Suisse has “Outperform” rating and $151 target. Cowen & Co maintained Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) rating on Wednesday, July 5. Cowen & Co has “Hold” rating and $10500 target. The stock of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has “Hold” rating given on Monday, August 24 by Vetr. Barclays Capital upgraded the shares of VRTX in report on Wednesday, July 19 to “Overweight” rating. The rating was maintained by Maxim Group on Wednesday, July 19 with “Buy”.

Brookside Capital Management Llc increased Godaddy Inc stake by 496,310 shares to 1.68 million valued at $71.22M in 2017Q2. It also upped Ishares Tr (Put) (IWM) stake by 2,900 shares and now owns 12,500 shares. Avexis Inc was raised too.

Investors sentiment increased to 1.51 in Q2 2017. Its up 0.20, from 1.31 in 2017Q1. It increased, as 31 investors sold VRTX shares while 154 reduced holdings. 98 funds opened positions while 181 raised stakes. 231.33 million shares or 0.08% less from 231.51 million shares in 2017Q1 were reported. Everence Capital Mngmt Inc reported 7,012 shares or 0.22% of all its holdings. Fmr Llc holds 18.48 million shares or 0.3% of its portfolio. Utd Automobile Association, Texas-based fund reported 160,555 shares. Warren Averett Asset Mngmt Ltd Liability Co accumulated 2,217 shares. Quantbot Technology Lp holds 0.08% or 6,841 shares in its portfolio. Pioneer Invest Mgmt accumulated 1.33 million shares. Moreover, Parkside Bancorporation And has 0.02% invested in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) for 326 shares. Arrow owns 0.01% invested in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) for 300 shares. British Columbia Invest Management Corp holds 0.22% or 213,681 shares in its portfolio. Apg Asset Nv reported 69,168 shares stake. Cibc Markets Corp reported 53,748 shares stake. Colorado-based Institute For Wealth Ltd Llc has invested 0.19% in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Wexford Cap Lp holds 0.03% of its portfolio in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) for 2,800 shares. Tiaa Cref Investment Management Limited Liability Com owns 2.08 million shares. Nicholas Invest Prns LP holds 33,000 shares.

Bluestein R H & Company decreased Pioneer Natural Resources (NYSE:PXD) stake by 7,971 shares to 290,317 valued at $46.33 million in 2017Q2. It also reduced Ibm Corp (NYSE:IBM) stake by 17,076 shares and now owns 90,294 shares. Southwest Airlines Co (NYSE:LUV) was reduced too.